Trial Details

Not Recruiting
Basic Information
Clinical ID c5037
Identifier IRCT20191105045340N2
Trial Title The effect of bromelain supplementation on disease activity and quality of life in patients with inflammatory bowel disease
Trial URL Visit Original Page
Study Information
Study Results

NULL
Conditions Condition 1: Crohn's disease. Condition 2: Ulcerative colitis. Crohn's disease [regional enteritis] Ulcerative colitis
Interventions Intervention 1: Intervention group: They will receive 2 capsules of 500 (gdu) containing bromelain manufactured by Salamat Parmon Amin company for 8 weeks, 1 hour before or 2 hours after food. Intervention 2: Control group: They will receive 2 capsules o
Participant Information
Sponsor Iran University of Medical Sciences
City NULL
Country/Region Iran
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type interventional
Phase NULL
Time Information
Start Date NULL
Primary Completion Date NULL
Completion Date NULL